JOURNAL ARTICLE
OBSERVATIONAL STUDY
Add like
Add dislike
Add to saved papers

Competitive interaction between chronic obstructive pulmonary disease and CHA 2 DS 2 -VASc score in predicting incident atrial fibrillation.

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, and an emerging risk factor for atrial fibrillation (AF). CHADS2 and CHA2 DS2 -VASc scores are significantly associated with incident AF independently of other risk factors. The aim of this study was to demonstrate a possible interaction between COPD and CHA2 DS2 -VASc in predicting incident AF.

METHODS: This observational prospective cohort study included 4322 Caucasians with cardiovascular risk factors, stratified by CHA2DS2-VASc score (>2 vs <2) and presence/absence of COPD. To detect AF appearance, patients underwent, every 6months, physical examination, standard 12‑lead electrocardiogram and routine laboratory tests.

RESULTS: COPD prevalence was significantly higher in patients with CHA2 DS2 -VASc≥2 vs CHA2 DS2 -VASc<2 category (13.3% vs 10.5%, P=0.009). During the follow-up, 589 cases of AF were documented (3.8 events/100 patients-year). COPD+ showed a significantly higher incidence of AF vs COPD- patients (17.4 vs 8.4 events/100 patients-year, P<0.0001). In Cox regression models both CHA2 DS2 -VASc score (HR=4.70, 95% CI=3.63-6.08) and COPD (HR=2.04, 95% CI=1.69-2.48) significantly predicted the incidence rate of AF; this was also confirmed introducing the two variables into the same Cox model. A significant competitive interaction between CHA2 DS2 -VASc and COPD was found in a Cox model in patients with CHA2 DS2 -VASc<2 (HR=8.45, 95% CI=5.20-13.74) than in those with CHA2 DS2 -VASc≥2.

CONCLUSIONS: COPD is an independent and strong predictor of incident AF. The presence of COPD increases the HR for incident AF about five times in patients with CHA2 DS2 VASc score<2, while the coexistence of a CHA2 DS2 Vasc score≥2 minimizes the prognostic significance of COPD.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app